chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Case number PHEH2014US022348, is an initial spontaneous report received from a nurse on 05 Nov 2014. This report refers to a patient of unknown age and gender. Nurse reported that one patient received an expired dose of MENVEO (batch number: A12102) intramuscularly on 03 Nov 2014. No adverse event was reported following the medication error. No further information was provided.
Received vaccines 9:30am, reports itchiness w/in 1 hr of vaccinations. Hives, head, neck, face developed 3 hours later. No breathing difficulties, sent to ER for Rx and observation.
Vomitting, chills, fever, body aches. All symptoms were gone about 12 hours after onset
3/28/03 Temp 97-4 (ear) smiling, happy, red bumps on face crust over (4 crusted lesions) (started 2 days after). Few lesions on abdomen (1 papule), back and face (2 pink papules). Assumed chicken pox; ? vaccine reaction. No treatment.
I'm just reporting since this was my 1st dose and it seems to be uncommon to have a fever with the first dose. By 3:00pm on the day of the shot I had a fever of 100.4. It escalated to over 102 in the evening and then leveled off around 101 and stayed that way until around 4 or 5 am when the fever broke. Arm soreness was pretty intense until the fever broke and then was significantly improved. I had a headache, some mild nausea throughout the day after the vaccine. Headache and nausea were pretty strong on the 2nd morning after the vaccine and seem to be going away now in the afternoon.  My arm is no longer sore on the 2nd day after vaccine.
17JUL92 recvd Engerix-B & 18JUL92 devel rash, generalized itching & lesions on abdomen; called MD;
he is in about a 5 out of 10 pain in right arm, painful to touch, cant lift up, and its a painful pimple where he rcvd the vaccine
Fever; Headaches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEADACHE (Headaches) and FATIGUE (Fatigue) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), HEADACHE (Headaches) and FATIGUE (Fatigue). At the time of the report, PYREXIA (Fever), HEADACHE (Headaches) and FATIGUE (Fatigue) outcome was unknown.            The  concomitant medications on use were not provided. No treatment information was provided.  The patient had no side effects after the first vaccine. Patient has not yet received his booster dose. No Physician contact in the case.   This case was linked to MOD-2022-440740, MOD-2022-440806 (Patient Link).
In early October 2021, I started having a lot of itching all over my body.  It continued, and I learned that I had developed a condition called "Dermatographia".  I now have to take daily allergy meds to keep it controlled and live comfortably.  This has been going on for about 6.5 months now.  I have seen an Allergist who prescribed the meds and ran several blood tests.
administering expired Infanrix to patient; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-month-old male patient who received DTPa (Infanrix) (batch number KG4M7, expiry date 6th February 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 13th June 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 13th June 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  GSK receipt date: 13-June-2022 Reporter's comment: The reporter was medical assistant. The reporter administered expired Infanrix to patient. No known side effects, for the patient. The reporter consented to follow up. Additional Supportive Information: The patient received infanrix which was already expired which led to expired vaccine used.
Everything started on the second day with pain in the arm where the vaccine was administered, that lasted two days and exactly one week later from receiving the vaccine started an allergic reaction with hives, that measured approximately 10inches wide. It was on the opposite arm to where the vaccine was given.
This case was reported by a nurse and described the occurrence of injection site pain in a 50 year old female subject who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. The subject's medical history included hypertension. Concurrent medications included Amlodipine (Norvasc) and Multivitamins (Multivitamin). The subject had no illness at the time of vaccination with Fluarix. On 09 November 2005 at 9:00 a.m., the subject received a dose of Fluarix in the left deltoid (lot AFLUA120AA). A previous dose of influenza virus vaccine (unknown manufacturer) was administered on 04 December 2003. On 09 November 2005, 10 minutes after vaccination with Fluarix, the subject experienced "a constant dull pain (4 on a pain scale of 1-10) in the left deltoid and shooting pain (5 on a pain scale of 1-10) on the left side of neck with flexion." The subject "took 600 mg ibuprofen (Motrin)." On 11 November 2005, at an unspecified time in the morning, the subject awoke with "dull pain." The subject "took 400 mg Motrin and was pain free by the afternoon" of 11 November 2005. The nurse considered the events to be related to vaccination of Fluarix.
Dizziness; This is a spontaneous report from a contactable consumer (patient reported himself). A 70-year-old male patient received first dose BNT162B2 (COVID 19, Pfizer, Formulation: Solution for injection, Lot number: EL8982) via an unspecified route of administration at left arm on 28Jan2021 07:00 PM at single dose for covid-19 immunization. The patient's medical history included hypertension, high cholesterol and osteoarthritis. Facility where the most recent COVID-19 vaccine was administered: Doctor's office/urgent care. Allergies to medications, food, or other products was none. Concomitant medications included meloxicam, hydrochlorothiazide, triamterene (TRIAMTERENE/HCTZ), losartan and atorvastatin. On 30Jan2021 02:00 AM, the patient experienced dizziness approximately 36 hours after injection. Multiple episodes over an 8 hour period. Had not re-occurred since then. The patient did not receive any treatment in response to the event. Outcome of the event was recovered on an unspecified date in 2021. Vaccine Facility information, ethnicity information and race information was available.
Patient called me yesterday afternoon and was hysterical as she said she was having chest pain and pain in her calf and was worried about a blood clot from her pfizer vaccine. I advised the patient to please get checked out immediately at the hospital and she stated she would. She then proceeded to tell me that she had some chest tightness after her first vaccine but had herself checked out by her PCP who just told her to follow up with a cardiologist. She was very anxious about getting the vaccine and it was believed that she may been having more of a panic attack than anything else. Upon talking with her further, she then further disclosed that her husband who got the  2nd vaccine the same day as she did had just died unexpectedly on Wednesday.
Information has been received from a licensed practical nurse concerning an adolescent patient who within the last two weeks (in August 2010) was vaccinated SC with a dose of VARIVAX (Merck) (lot number not provided). The nurse reported that the patient experienced normal redness around the injection area (in August 2010). The nurse reported that BENADRYL took care of the redness. At the time of the report the patient's outcome was unknown. The patient sought unspecified medical attention. This is one of several reports received from the same source. Additional information is not expected.
consumer reports that brother exp tachycardia 1 wk following vax; same occurrence last year;
site pain, itchy, temp dropped to 94, temp has risen since sunday, body aches, sweating and freezing, headaches, dizziness
Within two weeks of this vaccination (my third COVID vaccine, a full-dose Moderna when first two were Pfizer), my fatigue increased and amount of sleep needed to feel at all rested increased. The result has been that I can't stay awake more than 12 hours and then need to sleep equal number of hours as I was awake (so I sleep 12 hours if I was awake 12 hours). I have not recovered from this.   Last year, after my second dose of Pfizer, I had a similar adverse event that has not ended, in that I needed nap for 2-4 hours after being awake 12 hours, when previous to that time I did not need to nap after being awake 12 hours.  Therefore, the current result is that with the series of COVID vaccinations my fatigue has greatly increased and my stamina and energy have decreased; and I need much more sleep than before these vaccinations. Note I have chronic fatigue syndrome (have had it since 1994) and am very aware of my energy levels and fatigue levels, and my sleep needs. I am already on permanent disability through the Administration, prior to these adverse events.
Intramuscular flu injection given by pharmacist at site of shoulder joint, uppermost point on arm. I experienced constant ache in shoulder, spreading to back, arm, neck with pain level of 10 (scale 1-10). No use of arm, no mobility due to excruciating sharp pain upon the slightest movement. These symptoms began within 45 minutes of the injection and became progressively more painful. I am unable to shower or dress/undress myself, drive a car, do light housework, prepare meals, shop for food, carry or lift ordinary items, reach for things aloft and my sleep is disrupted every time I move. These symptoms still persist 3 1/2 weeks later. My orthopedic medical doctor, with aid of MRI report and x-ray of shoulder, diagnosed condition as extensive subdeltoid bursitis. Treatment consists of NAPROXEN, light home exercise, cold compresses. If no significant improvement in 3 weeks, doctor will administer cortisone injection.
Building pain throughout the evening in the arm of the injection site starting mildly around 5pm and increasing through the evening. Mild swelling of the arm around the injection site by 6pm. Chills developed around 6pm, no obvious fever. Aparent moderate fever with moderate chills developed around 9pm. Fever spiked around 10pm, chills continued. Consumed 2 benadryl tablets to assist with sleep. Fever, chills, and swelling were gone at time of waking up around 10am. Arm pain continued for 1 and 1/2 more days.
They never noticed before. He took an antibiotic recently and this happened afterward. (Had flu shot too.) Patient says this has been happening before his parents ever noticed. He says it happens when he is bored and dad agrees. Dad says church, watching a movie he has seen before. Says some jerking as he fell asleep (myoclonic).
Patient reported her throat was 'cool" and her left arm felt cool, also.  She felt "light-headed" five minutes after vaccination.  Dr. assessed patinet lying down in exam room.  Dr. reported that patient spoke without difficulty, no swelling or edema, no wheezing.  VS - WNL.  Patient consented to lay down for 20 minutes, then sat in chair for 10 minutes, left with her mother without having any additional problems.
I tested positive on 05/06/2022. I had non stop sneezing, runny nose and mild achy back. I tested my oxygen levels which were normal. No fever and I went on the prescribed Paxlovid. By Thursday or Friday, I was feeling better. On Sunday, I felt like it was over. So, we tested ourselves and we were negative. Then, this past Friday evening (05/13/2022) I started feeling poorly again and had the same symptoms as the first episode. Lower voice, throat felt weird, post nasal drip and mild back pain. I tested positive on Saturday (05/14/2022) The pain wasn't as bad as the first time but still bothersome. I called my doctor on Monday (05/16/2022) and he said I had a rebound COVID infection after Paxlovid.
Nasal bleeding; Sinus disorder; Laceration of hand; Blood pressure high; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Nasal bleeding), SINUS DISORDER (Sinus disorder), SKIN LACERATION (Laceration of hand), HYPERTENSION (Blood pressure high) and DIZZINESS (Dizziness) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    No Medical History information was reported.   On 26-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced EPISTAXIS (Nasal bleeding), SINUS DISORDER (Sinus disorder), SKIN LACERATION (Laceration of hand), HYPERTENSION (Blood pressure high) and DIZZINESS (Dizziness). At the time of the report, EPISTAXIS (Nasal bleeding), SINUS DISORDER (Sinus disorder), SKIN LACERATION (Laceration of hand), HYPERTENSION (Blood pressure high) and DIZZINESS (Dizziness) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: Blood pressure 165 out of 110 and Blood pressure 170 out of 100. On an unknown date, Heart rate: Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On unknown date, the patient experienced sinus issues with dizziness and spotting of blood from nose, worsening of cuts on hands, increased heart rate and high blood pressure. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Expired vaccine used. A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse in the military concerning a 28-year-old male. Neither medical history nor concomitant medications were reported. On 12-Jan-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. As of 18-Mar-2009, there was no adverse events associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Additional information was received on 18-Mar-2009 that indicated no adverse events were reported through the medical clinic and patient demographics were provided. Additional information was received on 12-May-2009: Product Complaint Investigation results.
hospitalized for lung cancer, tested due to fever. Otherwise asymptomatic for covid. Hospitalized from 1/22-1/24/22.Pt discharged home.
4 hr post - "fire" in chest, Left hand contracture x2 days Throbbing pain moving up and down Right leg, back of calf, knee, thigh, described as "charley horse". Vomiting x2 weeks. Ongoing feet and lower leg swelling (R>L), exertional SOB, hair loss, decrease in short term memory, scalp dysesthesia.
patient had already received prevnar 13 based on guidelines they should have been given pnemovax 23. we recieived a prescription from the dr for prevnar 20 and after givng the vaccine and checking records we discovered the patient had been given prevnar 13 5 years prior
fever and chills, tired. Fever ranged fom 99.5 to 101.0 over a 14 hour period. Fever and symptoms started approximately 21 hours following vaccinations. recovery complete. To combat symtoms drank fluids and took tylenol and ibupropin alternately.
Rash all over my upper body; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medication, food or any other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (MUNUFACTURER UNKNOWN) for unknown indication from unknown start date. On 12Apr2021, the patient experienced rash all over her upper body. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash all over upper body was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
COVID-19; This spontaneous report received from a patient via other company (Pfizer) concerned a 44 year old female of unknown ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid-19, and concurrent conditions included: drug allergy (unspecified), and other pre-existing medical conditions included: patient was not pregnant at the time of vaccination. The patient previously received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number in series was 1) (form, route of administration, batch number, dose were not reported, expiry: unknown) for prophylactic vaccination.  No adverse events were reported following vaccination with covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number in series was 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. The patient received non-company suspect Paxlovid (Nirmatrelvir; ritonavir) (form of admin, route of admin, batch number and expiry date were not reported) therapy started on 12-AUG-2022. Therapy ended on 17-AUG-2022 administered for covid-19 treatment. On 16-AUG-2022, the patient experienced covid-19 again (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from covid-19. This report was non-serious.; Sender's Comments: V0-Medical assessment comment not required as per standard procedure as the case is assessed as non-serious.
Information has been received from a physician's assistant concerning a female (age not reported) who on an unspecified date was vaccinated with first dose of Gardasil (lot # not reported) IM. The patient reported feeling nauseous in between the first and second dose of vaccine. Medical attention was not sought. The outcome of the nausea was not reported. No additional information was provided at the time of reporting. Additional information has been requested. 07/06/07 This is in follow-up to report(s) previously submitted on 3/14/2007. Information has been received from a physician's assistant concerning an 18 year old female (age not reported) who on 13-DEC-2006 was vaccinated with first dose of GARDASIL (lot # 655618/0186U) IM. The patient reported feeling nauseous in between the first and second dose of vaccine. Medical attention was not sought. The outcome of the nausea was not reported. No additional information was provided at the time of reporting. Additional information was received from the physician's assistant. On 13-FEB-2007, the patient was vaccinated with the second dose of GARDASIL (lot # 655618/0186U). The medication caused nausea on and off, but was not as bad with the second dose. The outcome of the nausea was not reported. No additional information is available.
got the shot and had a reaction / shingles in the worse place; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by patient himself/herself. The age group was not reported but was selected as an adult as per vaccine indication. The age at vaccination was not reported. The patient received the 1st dose of Shingles vaccine and had a reaction as shingles in the worse place. The patient stated he/she did not know if he/she would have 2nd dose. The follow-up would not possible as no contact details were available.
Information has been received from a physician concerning a 74 year old female patient with no pertinent medical history and no drug reactions or allergies who on 22-APR-2009 was vaccinated with ZOSTAVAX (Merck) (Lot# 663884/0131Y).  There was no concomitant medication.  After received the vaccine the patient experienced headache and herpectic lesions on her scalp.  The patient sought medical attention was seen at the practice.  At the time on the report on 05-MAY-2009 the patient had not recovered.  There were no laboratory diagnostics studies performed.  Additional information has been requested.
Received vaccine at 2:40pm with no immediate side effects. At 7pm woke up with a rapid heartrate. Rapid heart rate continued and led to symptoms of nausea, sweating, cramping , and feeling like i was going to pass out.  At that time i was concerned enough to consider going to hospital for treatment but was not in reach of a phone. Laid on floor and woke up within a few minutes. Once regained consciousness  felt fine. Did not receive any medical treatment as similar reactions have occurred with MMR vaccines and Flu vaccines. Approx 5-7 days of Arm pain/ache was the only additional symptom.
At about 4:00pm on 4/49/21 patient began to feel numbness on the right side of his face spanning from his jaw to his eye.  He described it as feeling like he received a Novocain shot in his mouth.  On 4/20/21, he is still experiencing the same feeling.  He has not taking anything for it, other than 2 Ibuprofen 200mg tablets...taken following his vaccination. Patient contacted his primary care physician was has not been seen in person.
PT REPORTED ITCHINESS AND REDNESS ON ARM.  IT LASTED 15 MINUTES.  PT REPORTED HEADACHE THAT LASTED 15 MINUTES.  PT WAS PROVIDED ICE PACK, 1 TABLET OF BENEDRYL, AND 1 WATER BOTTLE TO DRINK.  AFTER 15 MINTUES, PT REPORTED THAT EVERYTHING IS FINE AND SHE WAS READY TO LEAVE.  PT WAS ADVISED TO STAY 30 MINUTES FOR OBSERVATION.  PT DECLINED.  PT ALSO DECLINED FURTHER FOLLOW UP.
In 24 hours , had rashes/hives on face and neck which were itchy, also had slight wheezing . Contacted pharmacist who advised Benadryl and once I took it symptoms subsided.